Literature DB >> 30830535

Elective Paratracheal Lymph Node Dissection in Salvage Laryngectomy.

Janice L Farlow1, Andrew C Birkeland2, Andrew J Rosko1, Kyle VanKoevering1, Catherine T Haring1, Joshua D Smith1, J Chad Brenner1, Andrew G Shuman1, Steven B Chinn1, Chaz L Stucken1, Kelly M Malloy1, Jeffrey S Moyer1, Keith A Casper1, Scott A McLean1, Mark E P Prince1, Carol R Bradford1, Gregory T Wolf1, Douglas B Chepeha3, Matthew E Spector4.   

Abstract

BACKGROUND: Indications for and efficacy of paratracheal nodal dissection (PTND) in patients undergoing laryngectomy (salvage) for persistent or recurrent laryngeal squamous cell carcinoma are not well-defined.
METHODS: A retrospective cohort study was performed for patients undergoing salvage laryngectomy with clinically and radiographically negative neck disease between 1998 and 2015 (n = 210). Univariate and multivariate Cox regression analyses were performed.
RESULTS: PTND was performed on 77/210 patients (36%). The PTND cohort had a greater proportion of advanced T classification (rT3/rT4) tumors (78%) than subjects without PTND (55%; p = 0.001). There was a 14% rate of occult nodal metastases in the paratracheal basin; of these, 55% did not have pathologic lateral neck disease. Multivariate analysis controlling for tumor site, tumor stage, and pathologic lateral neck disease demonstrated that PTND was associated with improved overall survival [OS] (p = 0.03; hazard ratio [HR] 0.60, 95% confidence interval [CI] 0.38-0.96), disease-free survival [DFS] (p = 0.03; HR 0.55, 95% CI 0.31-0.96), and distant DFS survival (p = 0.01; HR 0.29, 95% CI 0.11-0.77). The rate of hypocalcemia did not differ between subjects who underwent bilateral PTND, unilateral PTND, or no PTND (p = 0.19 at discharge, p = 0.17 at last follow-up).
CONCLUSIONS: PTND at the time of salvage laryngectomy was more common in patients with rT3/rT4 tumors and was associated with improved OS and DFS, with no effect on hypocalcemia. In patients undergoing PTND, the finding of occult paratracheal metastases was often independent of lateral neck metastases.

Entities:  

Mesh:

Year:  2019        PMID: 30830535      PMCID: PMC6612310          DOI: 10.1245/s10434-019-07270-6

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  33 in total

Review 1.  Indications for selective neck dissection: when, how, and why.

Authors:  K T Robbins
Journal:  Oncology (Williston Park)       Date:  2000-10       Impact factor: 2.990

2.  Prognostic importance of paratracheal lymph node metastases.

Authors:  Robin E Plaat; Remco de Bree; Dirk J Kuik; Michiel W M van den Brekel; Alexander H van Hattum; Gordon B Snow; C René Leemans
Journal:  Laryngoscope       Date:  2005-05       Impact factor: 3.325

3.  Surgical treatment of laryngeal carcinoma with subglottis involvement.

Authors:  F Chiesa; N Tradati; L Calabrese; S Zurrida; F DePaoli; L Costa; R Molinari
Journal:  Oncol Rep       Date:  2001 Jan-Feb       Impact factor: 3.906

4.  Neck management in patients undergoing postradiotherapy salvage laryngeal surgery for recurrent/persistent laryngeal cancer.

Authors:  Tarik Y Farrag; Frank R Lin; Charles W Cummings; Wayne M Koch; Paul W Flint; Joseph A Califano; Jennifer Broussard; Gopal Bajaj; Ralph P Tufano
Journal:  Laryngoscope       Date:  2006-10       Impact factor: 3.325

5.  Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm.

Authors:  Susan Urba; Gregory Wolf; Avraham Eisbruch; Francis Worden; Julia Lee; Carol Bradford; Theodoros Teknos; Douglas Chepeha; Mark Prince; Norman Hogikyan; Jeremy Taylor
Journal:  J Clin Oncol       Date:  2005-12-27       Impact factor: 44.544

6.  Planned neck dissection as an adjunct to the management of patients with advanced neck disease treated with definitive radiotherapy: for some or for all?

Authors:  K Narayan; C H Crane; S Kleid; P G Hughes; L J Peters
Journal:  Head Neck       Date:  1999-10       Impact factor: 3.147

7.  Paratracheal lymph node involvement in advanced cancer of the larynx, hypopharynx, and cervical esophagus.

Authors:  Conrad V Timon; Mary Toner; Brendan J Conlon
Journal:  Laryngoscope       Date:  2003-09       Impact factor: 3.325

8.  Management of stage IV glottic carcinoma: therapeutic outcomes.

Authors:  Gershon J Spector; Donald G Sessions; Jason Lenox; Donald Newland; Joseph Simpson; Bruce H Haughey
Journal:  Laryngoscope       Date:  2004-08       Impact factor: 3.325

9.  Outcome of salvage total laryngectomy following organ preservation therapy: the Radiation Therapy Oncology Group trial 91-11.

Authors:  Randal S Weber; Brian A Berkey; Arlene Forastiere; Jay Cooper; Moshe Maor; Helmuth Goepfert; William Morrison; Bonnie Glisson; Andy Trotti; John A Ridge; K S Clifford Chao; Glenn Peters; D J Lee; Andrea Leaf; John Ensley
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2003-01

10.  Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis.

Authors:  Mitchell Machtay; Jennifer Moughan; Andrew Trotti; Adam S Garden; Randal S Weber; Jay S Cooper; Arlene Forastiere; K Kian Ang
Journal:  J Clin Oncol       Date:  2008-06-16       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.